Dr Samuel BitounRhumatologue à Le Kremlin-Bicêtre

2026The Journal of experimental medicinePubMed

Humans homozygous for rare or common hypomorphic IL23R variants are prone to tuberculosis

2026RMD openPubMed

Characteristics and outcomes of anti-Ku antibody-associated interstitial lung disease: a retrospective study of 60 patients

2026Presse medicale (Paris, France : 1983)PubMed

Immune checkpoint inhibitor-induced joint involvement

2026Presse medicale (Paris, France : 1983)PubMed

Sicca induced by immune checkpoint inhibitors

2026Methods in molecular biology (Clifton, N.J.)PubMed

Macrophage Cell Culture and Characterization by Serum Human AB in Health and Disease

2026Rheumatology (Oxford, England)PubMed

Characteristics of patients with isolated anti-Ku antibodies

2025Clinical and experimental immunologyPubMed

Expanded senescent CD8 T cells in IMID patients are associated with distinct inflammatory cytokines

2025RMD openPubMed

Cluster analysis identifies three clinical patterns of patients with systemic autoimmune diseases and anti-Ku antibodies

2025The Lancet. RheumatologyPubMed

CAR T-cell therapy in autoimmune diseases: where are we and where are we going?

2024HaematologicaPubMed

Clonal CD8(+) T-cell expansion is associated with complete response to elranatamab in refractory multiple myeloma

2024Annals of the rheumatic diseasesPubMed

2024 EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer

2024Bone reportsPubMed

High rate of progression to symptomatic multiple myeloma in patients with smoldering myeloma and isolated osteoporotic vertebral fracture

2024Rheumatic diseases clinics of North AmericaPubMed

Immune Checkpoint Inhibitor-induced Inflammatory Arthritis: Current Approaches to Management

2023RMD openPubMed

Immune checkpoint inhibitor rechallenge in patients who previously experienced immune-related inflammatory arthritis: a multicentre observational study

2021Journal of hematology & oncologyPubMed

Response to COVID-19 mRNA vaccination in multiple myeloma is conserved but impaired compared to controls

2021Med (New York, N.Y.)PubMed

Intestinal barrier dysfunction plays an integral role in arthritis pathology and can be targeted to ameliorate disease

2021HaematologicaPubMed

Light chain proteinuria revealing mu-heavy chain disease: an atypical presentation of Waldenström macroglobulinemia in two cases

2019Joint bone spinePubMed

Rheumatology residency in France: an assessment of the past and the unknowns of a new reform

2019Annals of the rheumatic diseasesPubMed

Valine 11 and phenylalanine 13 have a greater impact on the T-cell response to citrullinated peptides than the 70-74 shared epitope of the DRB1 molecule in macaques

2017Frontiers in immunologyPubMed

Both Systemic and Intra-articular Immunization with Citrullinated Peptides Are Needed to Induce Arthritis in the Macaque

2026RMD openPubMed

PD1(+) TIGIT(+) CD4(+) T cells predict response to anti-TNF in rheumatoid arthritis and spondyloarthritis

2026The Lancet. RheumatologyPubMed

Innovative therapies in rheumatoid arthritis: CAR T cells and bispecific antibodies

2023Rheumatology (Oxford, England)PubMed

Machine learning identifies a profile of inadequate responder to methotrexate in rheumatoid arthritis

2023JAMA network openPubMed

Response to Biologic Drugs in Patients With Rheumatoid Arthritis and Antidrug Antibodies

2023Rheumatology (Oxford, England)PubMed

Machine learning identifies a profile of inadequate responder to methotrexate in rheumatoid arthritis

2022Arthritis care & researchPubMed

Clinically effective concentration and risk of hydroxychloroquine retinopathy in systemic lupus erythematosus: walking on a thin line. Comment on the article by Garg et al

2019Annals of the rheumatic diseasesPubMed

Interaction between B-cell activation factor and methotrexate impacts immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis

2018Annals of the rheumatic diseasesPubMed

Methotrexate and BAFF interaction prevents immunization against TNF inhibitors

2026Autoimmunity reviewsPubMed

Bispecific T-cell engagers in autoimmune diseases: mechanisms of action, clinical evidence challenges, and therapeutic perspectives

2026Nature reviews. Drug discoveryPubMed

Next-generation immune cell engagers for B cell depletion in autoimmune diseases

2025Annals of the rheumatic diseasesPubMed

Systematic literature review and meta-analysis informing the EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer

2022Critical reviews in immunologyPubMed

Using Autoantibodies to Diagnose Systemic Autoimmune Diseases Triggered by Immune Checkpoint Inhibitors: A Clinical Perspective

2025The Lancet. RheumatologyPubMed

Machine learning to classify the focus score and Sjögren's disease using digitalised salivary gland biopsies: a retrospective cohort study

2025Rheumatology (Oxford, England)PubMed

Association between anti-SSA/SSB antibody profiles and patient-reported outcomes in primary Sjögren's disease

2024Rheumatic diseases clinics of North AmericaPubMed

Immune Checkpoint Inhibitor-induced Sicca Syndrome

2024Annals of the rheumatic diseasesPubMed

Obinutuzumab in patients with Sjogren's disease immunised against rituximab

2026RMD openPubMed

PD1(+) TIGIT(+) CD4(+) T cells predict response to anti-TNF in rheumatoid arthritis and spondyloarthritis

2022Frontiers in immunologyPubMed

Restoration of Default Blood Monocyte-Derived Macrophage Polarization With Adalimumab But Not Etanercept in Rheumatoid Arthritis

2022Frontiers in immunologyPubMed

Pegylation Reduces the Uptake of Certolizumab Pegol by Dendritic Cells and Epitope Presentation to T-Cells

2024Annals of the rheumatic diseasesPubMed

Obinutuzumab in patients with Sjogren's disease immunised against rituximab

2022Arthritis & rheumatology (Hoboken, N.J.)PubMed

Rituximab Impairs B Cell Response But Not T Cell Response to COVID-19 Vaccine in Autoimmune Diseases

2022RMD openPubMed

Very low rate of humoral response after a third COVID-19 vaccine dose in patients with autoimmune diseases treated with rituximab and non-responders to two doses

2025The Lancet. RheumatologyPubMed

Machine learning to classify the focus score and Sjögren's disease using digitalised salivary gland biopsies: a retrospective cohort study

2023Rheumatology (Oxford, England)PubMed

Machine learning identifies a profile of inadequate responder to methotrexate in rheumatoid arthritis

2022RMD openPubMed

Machine learning predicts response to TNF inhibitors in rheumatoid arthritis: results on the ESPOIR and ABIRISK cohorts

2022Critical reviews in immunologyPubMed

Using Autoantibodies to Diagnose Systemic Autoimmune Diseases Triggered by Immune Checkpoint Inhibitors: A Clinical Perspective

2024Rheumatology (Oxford, England)PubMed

Prophylaxis with tixagevimab/cilgavimab is associated with lower COVID-19 incidence and severity in patients with autoimmune diseases

2022Arthritis care & researchPubMed

Clinically effective concentration and risk of hydroxychloroquine retinopathy in systemic lupus erythematosus: walking on a thin line. Comment on the article by Garg et al

2024JBMR plusPubMed

Complete remission after a single bisphosphonate infusion in isolated bone Langerhans cell histiocytosis lesion: a case report and a narrative review of the literature

2025Annals of the rheumatic diseasesPubMed

Systematic literature review and meta-analysis informing the EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer

2026RMD openPubMed

PD1(+) TIGIT(+) CD4(+) T cells predict response to anti-TNF in rheumatoid arthritis and spondyloarthritis

2018 · Université Paris-Saclay (ComUE)

Mise au point de modèles animaux pour étudier la physiopathologie de la polyarthrite rhumatoïde et le rôle du méthotrexate dans la tolérisation